2020-02-20 最新期刊文獻

-
本日新增31篇文獻。收錄的5篇評論型文章，就目前所知的新型冠狀病毒進行包括分子流行病學、診斷準備工作的綜整，以及中醫在此類急重症中的應用。BMJ指出儘管新冠肺炎致死率低，但死亡總數已超過SARS和MERS。中國預防醫學雜誌提出兩篇關於大眾運輸及方艙醫院的衛生防護指南。中華醫誌提出減少病毒核酸檢測的偽陰性方法。Journal of Thrombosis & Haemostasis提出預後不良的患者在凝血參數上有明顯異常。European Radiology表示放射科醫生在這場疫情中可以發揮早期發現、早期治療的關鍵角色。Nature則指出目前已經有80多項治療冠狀病毒的臨床試驗正在展開。

  1. (2020). Calling all coronavirus researchers: keep sharing, stay open.  Nature, 578, 7. doi:10.1038/d41586-020-00307-x, https://doi.org/10.1038/d41586-020-00307-x 
  2. (2020). Rapid outbreak response requires trust.  Nature Microbiology, 5, 227-228. doi:10.1038/s41564-020-0670-8, https://doi.org/10.1038/s41564-020-0670-8 
  3. Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al. (2020). First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.  Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin, 25, doi:10.2807/1560-7917.ES.2020.25.6.2000094, https://doi.org/10.2807/1560-7917.ES.2020.25.6.2000094 
  4. Ceraolo C & Giorgi FM. (2020). Genomic variance of the 2019-nCoV coronavirus.  Journal of Medical Virology, doi:10.1002/jmv.25700, https://doi.org/10.1002/jmv.25700 
  5. Cheng ZJ & Shan J. (2020). 2019 Novel coronavirus: where we are and what we know.  Infection, doi:10.1007/s15010-020-01401-y, https://doi.org/10.1007/s15010-020-01401-y 
  6. Colson P, Rolain JM & Raoult D. (2020). Chloroquine for the 2019 novel coronavirus.  International Journal of Antimicrobial Agents, 105923. doi:10.1016/j.ijantimicag.2020.105923, https://doi.org/10.1016/j.ijantimicag.2020.105923 (需訂閱)
  7. Fang X, Zhao M, Li S, Yang L & Wu B. (2020). Changes of CT Findings in a 2019 Novel Coronavirus (2019-nCoV) pneumonia patient.  Qjm, doi:10.1093/qjmed/hcaa038, https://doi.org/10.1093/qjmed/hcaa038 
  8. Glauser W. (2020). Communication, transparency key as Canada faces new coronavirus threat.  CMAJ Canadian Medical Association Journal, 192, E171-E172. doi:10.1503/cmaj.1095846, https://doi.org/10.1503/cmaj.1095846 
  9. Gorse GJ, Donovan MM & Patel GB. (2020). Antibodies to Coronaviruses Are Higher in Older Compared with Younger Adults and Binding Antibodies Are More Sensitive than Neutralizing Antibodies in Identifying Coronavirus-Associated Illnesses.  Journal of Medical Virology, doi:10.1002/jmv.25715, https://doi.org/10.1002/jmv.25715 
  10. Habibzadeh P & Stoneman EK. (2020). The Novel Coronavirus: A Bird's Eye View.  International Journal of Occupational & Environmental Medicine, 11, 65-71. doi:10.15171/ijoem.2020.1921, https://doi.org/10.15171/ijoem.2020.1921 
  11. Han W, Quan B, Guo W, Zhang J, Lu Y, Feng G, et al. (2020). The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019.  Journal of Medical Virology, doi:10.1002/jmv.25711, https://doi.org/10.1002/jmv.25711 
  12. Kim H. (2020). Outbreak of novel coronavirus (COVID-19): What is the role of radiologists?.  European Radiology, doi:10.1007/s00330-020-06748-2, https://doi.org/10.1007/s00330-020-06748-2 
  13. Lewis D. (2020). Coronavirus outbreak: what's next?.  Nature, 578, 15-16. doi:10.1038/d41586-020-00236-9, https://doi.org/10.1038/d41586-020-00236-9 
  14. Liao X, Wang B & Kang Y. (2020). Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China.  Intensive Care Medicine, doi:10.1007/s00134-020-05954-2, https://doi.org/10.1007/s00134-020-05954-2 
  15. Liu Y, Li J & Feng Y. (2020). Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China.  Critical Care (London, England), 24, 56. doi:10.1186/s13054-020-2786-x, https://doi.org/10.1186/s13054-020-2786-x 
  16. Luk HKH, Li X, Fung J, Lau SKP & Woo PCY. (2019). Molecular epidemiology, evolution and phylogeny of SARS coronavirus.  Infection, Genetics & Evolution, 71, 21-30. doi:10.1016/j.meegid.2019.03.001, https://doi.org/10.1016/j.meegid.2019.03.001 
  17. Luo Y, Wang CZ, Hesse-Fong J, Lin JG & Yuan CS. (2019). Application of Chinese Medicine in Acute and Critical Medical Conditions.  American Journal of Chinese Medicine, 47, 1223-1235. doi:10.1142/S0192415X19500629, https://doi.org/10.1142/S0192415X19500629 
  18. Mahase E. (2020). Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate.  BMJ, 368, m641. doi:10.1136/bmj.m641, https://doi.org/10.1136/bmj.m641 
  19. Mallapaty S. (2020). Scientists fear coronavirus spread in countries least able to contain it.  Nature, 578, 348. doi:10.1038/d41586-020-00405-w, https://doi.org/10.1038/d41586-020-00405-w 
  20. Maxmen A. (2020). More than 80 clinical trials launch to test coronavirus treatments.  Nature, 578, 347-348. doi:10.1038/d41586-020-00444-3, https://doi.org/10.1038/d41586-020-00444-3 
  21. Nguyen TM, Zhang Y & Pandolfi PP. (2020). Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses.  Cell Research, doi:10.1038/s41422-020-0290-0, https://doi.org/10.1038/s41422-020-0290-0 
  22. Novel Coronavirus Pneumonia Emergency Response Key Places Protection and Disinfection Technology Team, Chinese Center for Disease Control and Prevention. (2020). 新型冠狀病毒肺炎流行期間方艙醫院衛生防護指南 [Health protection guideline of mobile cabin hospitals during Novel Coronavirus Pneumonia (NPC) outbreak].  Chung-Hua Yu Fang i Hsueh Tsa Chih [Chinese Journal of Preventive Medicine], 54, E006. doi:10.3760/cma.j.cn112150-20200217-00121, https://doi.org/10.3760/cma.j.cn112150-20200217-00121 
  23. Novel Coronavirus Pneumonia Emergency Response Key Places Protection and Disinfection Technology Team, Chinese Center for Disease Control and Prevention. (2020). 新型冠狀病毒肺炎客運場站及交通運輸工具衛生防護指南 [Health protection guideline of passenger transport stations and transportation facilities during novel coronavirus pneumonia (NCP) outbreak].  Chung-Hua Yu Fang i Hsueh Tsa Chih [Chinese Journal of Preventive Medicine], 54, E007. doi:10.3760/cma.j.cn112150-20200217-00130, https://doi.org/10.3760/cma.j.cn112150-20200217-00130 
  24. Pan L, Wang L & Huang X. (2020). How to face the novel coronavirus infection during the 2019-2020 epidemic: the experience of Sichuan Provincial People's Hospital.  Intensive Care Medicine, doi:10.1007/s00134-020-05964-0, https://doi.org/10.1007/s00134-020-05964-0 
  25. Roberts CC. (2019). Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development.  Human vaccines & Immunotherapeutics, 15, 2258-2263. doi:10.1080/21645515.2019.1634992, https://doi.org/10.1080/21645515.2019.1634992 
  26. Ryu S, Kim JJ, Cowling BJ & Kim C. (2019). Surveillance and public health response for travelers returning from MERS-CoV affected countries to Gyeonggi Province, Korea, 2016-2017.  Travel Medicine & Infectious Disease, 31, 101350. doi:10.1016/j.tmaid.2018.11.006, https://doi.org/10.1016/j.tmaid.2018.11.006 
  27. Shu L. (2020). Avoid stigmatizing names for 2019 novel coronavirus.  Nature, 578, 363. doi:10.1038/d41586-020-00458-x, https://doi.org/10.1038/d41586-020-00458-x 
  28. Tang N, Li D, Wang X & Sun Z. (2020). Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.  Journal of Thrombosis & Haemostasis, doi:10.1111/jth.14768, https://doi.org/10.1111/jth.14768 
  29. Wang SM, Huang KJ & Wang CT. (2019). Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release.  Journal of Medical Virology, 91, 1743-1750. doi:10.1002/jmv.25518, https://doi.org/10.1002/jmv.25518 
  30. Watts CH, Vallance P & Whitty CJM. (2020). Coronavirus: global solutions to prevent a pandemic.  Nature, 578, 363. doi:10.1038/d41586-020-00457-y, https://doi.org/10.1038/d41586-020-00457-y 
  31. Zhang R & Li JM. (2020). 如何減少新型冠狀病毒核酸檢測的"假陰性" [The way to reduce the"false negative results"of 2019 novel coronavirus nucleic acid detection].  Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal], 100, E008. doi:10.3760/cma.j.issn.0376-2491.2020.0008, https://doi.org/10.3760/cma.j.issn.0376-2491.2020.0008 

留言

張貼留言